Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy – Technology Networks
Technology Networks |
Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy
Technology Networks In a paper appearing in the June 29 edition of Cell, researchers led by Ben Youngblood, Ph.D., an assistant member of the St. Jude Department of Immunology, reported findings that explain the failure of a form of immunotherapy called immune checkpoint … |
